GlassScriptPhysician profile
David J Dixon
NPI 1952402331
$6,795.89
in general payments reported to CMS, 2019-2025
32 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $132 · 2021: $4,569 · 2022: $425 · 2023: $516 · 2024: $374 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,027 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.28 |
| Education | $119.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,163.32 | 2021-2023 | |
| Hologic Sales and Service, LLC | $565.99 | 2019-2025 | Aptima, Acessa Provu System |
| Astellas Pharma US INC | $542.84 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $373.79 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Glaxosmithkline, LLC. | $139.17 | 2023 | Shingrix, Fluarix Quadrivalent, Boostrix |
| Bayer Healthcare Pharmaceuticals INC. | $121.95 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $79.92 | 2021-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $78.50 | 2021 | |
| Momentis Surgical INC. | $69.00 | 2022 | |
| Coopersurgical, INC. | $68.26 | 2019-2022 | |
| Medicem INC. | $66.28 | 2021-2022 | |
| Ethicon US, LLC | $61.48 | 2022-2023 | Dermabond, Vistaseal |
| Roche Diagnostics Corporation | $39.08 | 2019-2021 | |
| Pfizer INC. | $38.21 | 2023-2024 | |
| Cgg Medical INC | $35.83 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $33.99 | 2024-2025 | Jada System |
| Avion Pharmaceuticals | $30.75 | 2022-2023 | Balcoltra |
| Sumitomo Pharma America, INC. | $27.97 | 2023-2024 | Myfembree |
| Duchesnay USA Incorporated | $25.53 | 2019 | |
| Mayne Pharma Commercial LLC | $24.60 | 2022 | |
| Therapeuticsmd, INC. | $23.96 | 2021 | |
| Sanofi Pasteur INC. | $21.62 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $21.61 | 2023 | Exparel |
| Molnlycke Health Care US, LLC | $20.39 | 2019 | |
| Exeltis, USA INC. | $18.08 | 2020 | |
| Millicent US INC | $17.52 | 2024 | Femring, Intrarosa |
| Olympus America INC. | $16.68 | 2021 | |
| Lilly USA, LLC | $16.12 | 2023 | Mounjaro |
| Davol INC. | $14.97 | 2019 | |
| Merck Sharp & Dohme LLC | $14.16 | 2019 | |
| Medtronic Vascular, INC. | $12.43 | 2019 | |
| Covidien LP | $11.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Dixon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.